KH5-20578-33025 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-07-14
Dose 1 — Pfizer-BioNTech
2022-07-19
Registered in v-safe
2022-07-19
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Fair · Site: Redness · Irritability/crying

Under 3 check-in
2022-07-20
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · Site: Redness · None

Under 3 check-in
2022-07-24
Health check-in — day 7, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-07-29
Survey response — day 14, dose 1, under 3
MedDRA: Pyrexia — Feeling: Fair

Free text: Low grade fever

MedDRA releases: 2024-11 · check-in free text available
2022-08-06
Health check-in — day 21, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-08-11
Survey response — day 28, dose 1, under 3
MedDRA: Cough, Pyrexia, Rhinorrhoea, Sputum discoloured — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Runny nose, yellow mucus, cough, 103F fever

MedDRA releases: 2024-11 · check-in free text available
2022-08-11
Report sent to call center — day 28, dose 1, under 3
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-08-12
Call 1 — Left Voicemail
2022-08-18
Health check-in — day 35, dose 1, under 3
Feeling: Poor

Under 3 check-in
2022-08-25
Health check-in — day 42, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-09-03
Dose 2 — Pfizer-BioNTech
2022-09-06
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Good · Irritability/crying

Under 3 check-in
2022-09-07
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Fair · Irritability/crying

Under 3 check-in
2022-09-08
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-09-09
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-09-13
Health check-in — day 7, dose 2, under 3
Feeling: Fair · Irritability/crying

Under 3 check-in
2022-09-17
Health check-in — day 14, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-09-25
Health check-in — day 21, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-10-01
Health check-in — day 28, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-10-10
Survey response — day 35, dose 2, under 3
MedDRA: Cough, Rhinorrhoea — Feeling: Good

Free text: Runny nose, cough

MedDRA releases: 2024-11 · check-in free text available
2022-10-16
Survey response — day 42, dose 2, under 3
MedDRA: Cough, Upper-airway cough syndrome — Feeling: Good · Be unable to work or attend school

Free text: Postnasal drip, cough- cold weather

MedDRA releases: 2024-11 · check-in free text available
2022-12-03
Survey response — 3 months, dose 2, under 3
MedDRA: Irritability, Pyrexia, Sputum discoloured — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Irritability, fever, yellow mucus

MedDRA releases: 2024-11 · check-in free text available
2023-03-05
Survey response — 6 months, dose 2, under 3
MedDRA: Exposure to SARS-CoV-2 — Feeling: Good · Be unable to work or attend school

MedDRA releases: 2024-11

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-07-14	Pfizer-BioNTech	No
2	2022-09-03	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2022-08-11	Unsuccessful

Free text

Release 12 (Under 3) — day 14, dose 1, under 3

2022-07-29

Symptoms: Low grade fever

Release 12 (Under 3) — day 28, dose 1, under 3

2022-08-11

Symptoms: Runny nose, yellow mucus, cough, 103F fever

Release 12 (Under 3) — day 35, dose 2, under 3

2022-10-10

Symptoms: Runny nose, cough

Release 12 (Under 3) — day 42, dose 2, under 3

2022-10-16

Symptoms: Postnasal drip, cough- cold weather

Release 12 (Under 3) — 3 months, dose 2, under 3

2022-12-03

Symptoms: Irritability, fever, yellow mucus

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Cough	·	·	✓
SD	Exposure to SARS-CoV-2	·	·	✓
SD	Irritability	·	·	✓
SD	Pyrexia	·	·	✓
SD	Rhinorrhoea	·	·	✓
SD	Sputum discoloured	·	·	✓
SD	Upper-airway cough syndrome	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release